Literature DB >> 8252218

Laparoscopy for staging in pancreatic carcinoma.

C Fernández-del Castillo1, A L Warshaw.   

Abstract

Pancreatic cancer is the gastrointestinal malignancy with the worst prognosis. At the time of diagnosis, only 15% of patients are resectable (and potentially curable), 40% have localized but unresectable tumours, and 45% distant metastases. Computerized tomography, angiography, and laparoscopy allow for adequate staging in this neoplasm. The latter is useful for identifying the small (1-2 mm) peritoneal and liver implants which, in our experience, are present in 27% of patients with tumours of the pancreatic head and in 65% of those with cancers of the body and tail of the pancreas. Peritoneal cytology may also be performed at the time of laparoscopy, and will be positive for malignant cells in 20-30% of cases indicating a bad prognosis.

Entities:  

Mesh:

Year:  1993        PMID: 8252218     DOI: 10.1016/0960-7404(93)90055-4

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  4 in total

1.  Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies.

Authors:  Charles M Vollmer; Jeffrey A Drebin; William D Middleton; Sharlene A Teefey; David C Linehan; Nathaniel J Soper; Christopher J Eagon; Steven M Strasberg
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  [Diagnosis of pancreatic carcinoma].

Authors:  J Schmielau; W H Schmiegel
Journal:  Med Klin (Munich)       Date:  1997-09-15

3.  PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer.

Authors:  Richard Kim; Gopi Prithviraj; Nishi Kothari; Greg Springett; Mokenge Malafa; Pamela Hodul; Jongphil Kim; Binglin Yue; Brian Morse; Amit Mahipal
Journal:  Clin Nucl Med       Date:  2015-11       Impact factor: 7.794

4.  Needle biopsy for suspicious lesions of the head of the pancreas: pitfalls and implications for therapy.

Authors:  K M Itani; T V Taylor; L K Green
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.